When Should You SELL Your Stocks (8 Reasons to Sell Your Stocks) Click to watch on Youtube.

$1.52 (2.70%)

Volume: 1.195M

Closed: Aug 05, 2022

Hollow Logo Score: 3.235

Epizyme Stock Forecast

BUY NASDAQ:EPZM
$1.52 (2.70%)

Volume: 1.195M

Closed: Aug 05, 2022

Score Hollow Logo 3.235

EPZM Price Targets and Analyst Ratings NASDAQ:EPZM

EPZM Forecast. What You Should Know.

EPZM Historical Ratings and Targets

Unlock All Premium Features! Go Premium! Only $19.90/Month

Unlock the Top 5 candidates in every list
Unlock full Ultimate List Builder
Golden Star lists & Auto Portfolios
Possible Runners & Moving Average lists
Ad-free browsing
Save data in PDF

About Epizyme

Epizyme Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States. The company offers Tazemetostat for the treatment of metastatic or locally advanced epithelioid sarcoma for adults and pediatric patients. It also develops R-CHOP in front-line patients with high risk diffuse large B-cell lymphoma; and PARP inhibitor in pa... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT